iNtRON Biotechnology, Inc. (KOSDAQ:048530)
2,485.00
-40.00 (-1.58%)
Nov 20, 2026, 3:30 PM KST
iNtRON Biotechnology Market Cap
iNtRON Biotechnology has a market cap or net worth of 76.77 billion as of November 20, 2026. It is the 28,536th most valuable company in the world and the 1,368th biggest in South Korea. Its market cap has decreased by 33.56% in one year.
Market Cap
76.77B
Enterprise Value
38.34B
Revenue
5.74B
Global Rank
Country Rank
#1,368 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since January 26, 2011, iNtRON Biotechnology's market cap has decreased from 95.30B to 76.77B, a decrease of -19.45%. That is a compound annual growth rate of -1.36%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 76.77B | -25.29% |
| Dec 30, 2025 | 102.75B | -44.03% |
| Dec 30, 2024 | 183.56B | -37.01% |
| Dec 28, 2023 | 291.42B | 7.98% |
| Dec 29, 2022 | 269.88B | -61.99% |
| Dec 30, 2021 | 710.00B | -22.41% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Helixmith | 147.58B |
| NeoImmuneTech | 140.29B |
| Anterogen.Co.,Ltd. | 131.78B |
| MedPacto | 124.76B |
| HLB Therapeutics | 107.09B |
| Vaxcell-Bio Therapeutics | 82.80B |
| Genexine | 81.68B |
| Amicogen | 63.69B |